ESC 365 - SGLT2 inhibitors: all there is to say?

HFA Premium Access

SGLT2 inhibitors: all there is to say?

Session: State of the art: new treatments for heart failure

Topic: Chronic Heart Failure

Speaker: Professor J. McMurray (Glasgow, GB)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Professor John J V McMurray

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

127 presentations

19 followers

3 more presentations in this session

The new comer: vericiguat

Speaker: Professor G. Rosano (London, GB)

Moving forward with MRAs

Speaker: Professor G. Filippatos (Athens, GR)

Obesity treatment for HFpEF

Speaker: Professor S. Anker (Berlin, DE)

Access the full session

State of the art: new treatments for heart failure

Speakers: Professor J. McMurray, Professor G. Rosano, Professor G. Filippatos, Professor S. Anker

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources